Expression of Bcl-2 and its homologues in human eosinophils modulation by interleukin-5

American Journal of Respiratory Cell and Molecular Biology

Volumn 20, Issue 4, 1999, Pages 720-728

  Dewson, Grant ^a   Walsh, Garry M ^a,c   Wardlaw, Andrew J ^a,b  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b GLENFIELD HOSPITAL   (United Kingdom)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BAX PROTEIN, HUMAN; BCL2L1 PROTEIN, HUMAN; INTERLEUKIN 5; MESSENGER RNA; ONCOPROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL X; RECOMBINANT PROTEIN;

APOPTOSIS; ARTICLE; CELL STRAIN HL 60; CELL SURVIVAL; DRUG EFFECT; EOSINOPHIL; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; IMMUNOLOGY; KINETICS; LEUKEMIA CELL LINE; PHYSIOLOGY; PROTO ONCOGENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; CELL SURVIVAL; EOSINOPHILS; GENE EXPRESSION REGULATION; GENES, BCL-2; HL-60 CELLS; HUMANS; INTERLEUKIN-5; JURKAT CELLS; KINETICS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 0033110882     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.20.4.3453     Document Type: Article

References (58)

1. Wardlaw, A. J., R. Moqbel, and A. B. Kay. 1995. Eosinophils: biology and role in disease. Adv. Immunol. 60:151-266.
2. Kroegel, C. 1990. The role of eosinophils in asthma. Lung 168(Suppl.):5-17.
3. Gleich, G. J. 1990. The eosinophil and bronchial asthma. J. Allergy Clin. Immunol. 85:422-436.
4. Kephart, G. M., G. J. Gleich, D. H. Connor, D. W. Gibson, and S. J. Ackerman. 1984. Deposition of eosinophil granule major basic protein onto microfilariae of Onchocerca volvurus in the skin of patients treated with diethylcarbamazine. Lab. Invest. 55:51-61.
5. Wardlaw, A. J., G. M. Walsh, and F. A. Symon. 1994. Mechanisms of eosinophil and basophil migration. Allergy 49:797-807.
6. Stern, M., L. Meagher, J. S. Savill, and C. Haslett. 1991. Programmed cell death in the eosinophil leads to phagocytosis by macrophages and is modulated by IL-5. J. Immunol. 148:3543-3549.
7. Owen, W. F., M. F. Rothenberg, D. S. Silberstein, J. C. Gasson, R. L. Stevens, K. F. Austen, and R. J. Soberman. 1987. Regulation of human eosinophil viability, density and function by granulocyte-macrophage colony-stimulating factor in the presence of 3T3 fibroblasts. J. Exp. Med. 166:129-140.
8. Moqbel, R., F. Levi-Schaffer, and A. B. Kay. 1994. Cytokine generation by eosinophils. J. Allergy Clin. Immunol. 94:1183-1188.
9. Her, E., J. Frazer, K. F. Austen, and W. F. Owen, Jr. 1991. Eosinophil hematopoietins antagonise the programmed cell death of eosinophils: cytokine and glucocorticoid effects on eosinophils maintained by endothelial cell-conditioned medium. J. Clin. Invest. 81:1982-1987.
10. Ramis, I., S. Finotto, J. Dolovich, J. Marshall, and M. Jordana. 1995. Increased survival of nasal polyp eosinophils. Immunol. Lett. 45:219-221.
11. Simon, H.-U., S. Yousefi, C. Schranz, A. Schapowal, C. Bachert, and K. Blaser. 1997. Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia. J. Immunol. 158:3902-3908.
12. Yamaguchi, Y., T. Suda, S. Ohta, K. Tominaga, Y. Miura, and T. Kasahara. 1991. Analysis of the survival of mature eosinophils: interleukin-5 prevents apoptosis in mature human eosinophils. Blood 78:2542-2547.
13. Gleich, G. J., and C. R. Adolphson. 1986. The eosinophil leukocyte: structure and function. Adv. Immunol. 39:177-253.
14. Cohen, J. J. 1993. Apoptosis: mechanisms of apoptosis. Immunol. Today 14: 126-130.
15. Dewson, G., A. J. Wardlaw, and G. M. Walsh. 1996. Human eosinophils: apoptosis versus survival in the mediation of inflammation. Apoptosis 1: 111-118.
16. Haslett, C., J. S. Savill, M. K. B. Whyte, M. Stern, I. Dransfield, and L. C. Meagher. 1994. Granulocyte apoptosis and the control of inflammation. Phil. Trans. Soc. Lond. 345:327-333.
17. Woolley, K. L., P. G. Gibson, K. Carty, A. J. Wilson, S. H. Twaddell, and M. J. Woolley. 1996. Eosinophil apoptosis and the resolution of airway inflammation in asthma. Am. J. Respir. Crit. Care Med. 154:237-243.
18. Beauvais, F., L. Micehl, and L. Dubertret. 1995. Human eosinophils in culture undergo a striking and rapid shrinkage during apoptosis: role of K+ channels. J. Leuk. Biol. 57:851-855.
19. Martin, S. J., C. P. M. Reutlingsperger, A. J. McGahon, A. Radar, R. C. van-Schie, D. M. LaFace, and D. R. Green. 1995. Early distribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J. Exp. Med. 182:1545-1556.
20. Allen, T. R., W. J. Hunter, III, and D. K. Agrawal. 1997. Morphological and biochemical characterisation and analysis of apoptosis. J. Pharmacol. Toxicol. Methods 37:215-228.
21. Walsh, G. M., G. Dewson, A. J. Wardlaw, F. Levi-Schaffer, and R. Moqbel. 1998. A comparative study of different methods for the assessment of apoptosis and necrosis in human eosinophils. J. Immunol. Methods 217:153-163.
22. Matsumoto, K., R. P. Schleimer, H. Saito, Y. Iikura, and B. S. Bochner. 1995. Induction of apoptosis in human eosinophils by anti-Fas treatment in vitro. Blood 86:1437-1443.
23. Hebestreit, H., S. Yousefi, I. Balatti, M. Weber, R. Crameri, D. Simon, K. Hartung, A. Schapowal, K. Blaser, and H.-U. Simon. 1996. Expression and function of the Fas receptor on human blood and tissue eosinophils. Eur. J. Immunol. 26:1775-1780.
24. Walsh, G. M., M. L. Wiliamson, F. A. Symon, G. B. Willars, and A. J. Wardlaw. 1996. Ligation of CD69 induces apoptosis and cell death in human eosinophils cultured with granulocyte-macrophage colony-stimulating factor. Blood 87:2815-2821.
25. Meagher, L. C., J. M. Cousin, J. R. Seckl, and C. Haslett. 1996. Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. J. Immunol. 156:4422-4428.
26. Anwar, A. R. E., R. Moqbel, G. M. Walsh, A. B. Kay, and A. J. Wardlaw. 1993. Adhesion to fibronectin prolongs eosinophil survival. J. Exp. Med. 177:839-844.
27. Walsh, G. M., F. A. Symon, and A. J. Wardlaw. 1995. Human eosinophils preferentially survive on tissue fibronectin compared with plasma fibronectin. Clin. Exp. Allergy 25:1128-1136.
28. Takanaski, S., R. Nonaka, Z. Xing, P. O'Byrne, J. Dolovich, and M. Jordana. 1994. Interleukin-10 inhibits lipopolysaccharide-induced survival and cytokine production by human peripheral blood eosinophils. J Exp. Med. 180:711-715.
29. Tsujimoto, Y., J. Cossman, E. Jaffe, and C. M. Croce. 1985. Involvement of the bcl-2 gene in human follicular lymphoma. Science 228:1440-1443.
30. Tsujimoto, Y., and C. M. Croce. 1986. Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc. Natl. Acad. Sci. USA 83:5214-5218.
31. Hengartner, M. O., R. E. Ellis, and H. R. Horvitz. 1992. Caenorhabditis elegans gene ced-9 protects cells from programmed cell death. Nature 356: 494-499.
32. Hengartner, M. O., and H. R. Horvitz. 1994. Activation of C. elegans cell death protein Ced-9 by an amino-acid substitution in a domain conserved in Bcl-2. Nature 369:318-320.
33. Kroemer, G. 1997. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nature Med. 3:614-620.
34. Boise, L. H., M. Gonzalez-Garcia, C. E. Postema, L. Ding, T. Lindsten, L. A. Turka, X. Mao, G. Nunez, and C. B. Thompson. 1993. Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597-608.
35. L. J. Biol. Chem. 271:6306-6312.
36. Sato, T., M. Hanada, S. Bodrug, S. Irie, N. Iwama, L. Boise, C. Thompson, E. Golemis, L. Fong, H.-G. Wang, and J. Reed. 1994. Interactions among the members of the bcl-2 family analysed with a yeast two-hybrid system. Proc. Natl. Acad. Sci. USA 91:7834-7838.
37. Wang, H.-G., U. R. Rapp, and J. C. Reed. 1996. Bcl-2 targets the protein kinases Raf-1 to mitochondria. Cell 87:629-638.
38. Reed, J. C. 1994. Bcl-2 and the regulation of programmed cell death. J. Cell Biol. 124:1-6.
39. Zou, H., W. J. Henzel, X. Liu, A. Lutschg, and X. Wang. 1997. Apaf-1, a human protein homologous to C. elegans Ced-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90:405-413.
40. Kluck, R. M., E. Bossy-Wetzel, D. R. Green, and D. D. Newmeyer. 1997. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275:1132-1136.
41. Ohta, K., K. Iwai, Y. Kasahara, N. Taniguchi, S. Krajewski, J. C. Reed, and T. Miyawaki. 1995. Immunoblot analysis of cellular expression of Bcl-2 family proteins, Bcl-2, Bcl-x, and Mcl-1, in human peripheral blood and lymphoid tissues Int. Immunol. 7:1817-1825.
42. Iwai, K., T. Miyawaki, T. Takizawa, A. Konno, K. Ohta, A. Yachie, H. Seki, and N. Taniguchi. 1994. Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes and neutrophils. Blood 84:1201-1208.
43. Lagasse, E., and I. L. Weissman. 1994. Bcl-2 inhibits apoptosis of neutrophils but not their engulfment by macrophages. J Exp. Med. 179:1047-1052.
44. Druilhe, A., M. Arock, L. Le Goff, and M. Pretolani. 1998. Human eosinophils express Bcl-2 family proteins: modulation of Mcl-1 expression by IFN-γ Am. J. Respir. Cell Mol. Biol. 18:315-322.
45. Ochiai, K., M. Kagami, R. Matsumura, and H. Tomioka. 1997. IL-5 but not interferon-gamma (IFN-γ) inhibits eosinophil apoptosis by up-regulation of bcl-2 expression. Clin. Exp. Immunol. 107:198-204.
46. Yasui, K., T. Nakazawa, K. Agematsu, and A. Komiyama. 1997. Theophylline accelerates human granulocyte apoptosis not via phosphodiesterase inhibition. J. Clin. Invest. 100:1677-1684.
47. Oltvai, Z. N., C. L. Milliman, and S. J. Korsmeyer. 1993. Bcl-2 heterodimeriscs in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609-619.
48. Zhou, M., S. D. Demo, T. N. McClure, R. Crea, and C. M. Bitler. 1998. A novel splice variant of the cell death-promoting protein Bax. J. Biol. Chem. 273:11930-11936.
49. L forms an ion channel in synthetic lipid membranes. Nature 385:353-357.
50. L-Bak complex: recognition between regulators of apoptosis. Science 275:983-986.
51. Cheng, E. H.-Y., D. G. Kirsch, R. J. Clem, R. Ravi, M. B. Kastan, A. Bedi, K. Ueno, and M. Hardwick. 1997. Conversion of Bcl-2 to a Bax-like death effector by caspases. Science 278:1966-1968.
52. L through caspase interaction. Proc. Natl. Acad. Sci. USA 95:554-559.
53. Rosse, T., R. Olivier, L. Monney, M. Rager, S. Conus, I. Fellay, B. Jansen, and C. Bonner. 1998. Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c. Nature 391:496-499.
54. Yang, E., J. Zha, J. Jocket, L. H. Boise, C. B. Thompson, and S. J. Korsmeyer. 1995. Bad, a heteromeric partner for Bcl-xL and Bcl-2, displaces Bax and promotes cell death. Cell 80:285-291.
55. Takayama, S., T. Sato, S. Krajewski, K. Kochel, S. Irie, J. A. Millan, and J. C. Reed. 1995. Cloning anPd functional analysis of Bag-1: a novel Bcl-2-binding protein with anti-cell death activity. Cell 80:279-284.
56. Gibson, L., S. P. Holmgreen, D. C. S. Huang, O. Bernard, N. G. Copeland, N. A. Jenkins, G. R. Sutherland, E. Baker, J. M. Adams, and S. Cory. 1996. bcl-w, a novel member of the bcl-2 family, promotes cell survival. Oncogene 13:665-675.
57. Symon, F. A., G. M. Walsh, S. R. Watson, and A. J. Wardlaw. 1994. Eosinophil adhesion to nasal polyp endothelium is P-selectin dependent. J. Exep. Med. 180:371-377.
58. Symon, F. A., G. M. Walsh, S. R. Watson, and A. J. Wardlaw. 1994. Eosinophil adhesion to nasal polyp endothelium is P-selectin dependent. J. Exp. Med. 180:371-377.